Dr Peter Ang was the editor and main author of a book on breast cancer, “Illustrative Cases in Breast Cancer” (2006). As an active researcher and cancer specialist, Dr Ang has also been a reviewer for several reputable medical journals, including American Journal of Clinical Oncology, World Journal of Surgical Oncology, Annals of Academy of Medicine Singapore and Oncology journal.
He had investigated with collaborators on breast cancer in young women less than 35 years, non-small cell lung cancer using chemoradiotherapy, irinotecan (CPT-11 or Camptosar) in colorectal cancer patients, gemcitabine with pegylated liposomal doxorubicin (Caelyx, Doxil) as first-line chemotherapy in Asian women with metastatic breast cancer, lapatinib for Her2 positive locally advanced or metastatic breast cancer, and pharmacogenomic and pharmacogenetic studies in Asian breast cancer patients for drugs like doxorubicin, vorinostat and others.
Dr Ang is currently a Visiting Consultant to National Cancer Centre Singapore and is actively involved in research and teaching. He had been an active clinical teacher with the National University of Singapore and recognised as a breast cancer specialist, he had been a speaker for Breast Cancer Foundation, Association of Women Doctors of Singapore and Singapore Cancer Society. Being recognised as an authority in breast cancer, he had been one of the speakers for the first Singapore Medical Oncology Review Course (2007) and the first regional Asian Oncology Summit, 2009. He had also been one of the regional keynote speakers for the Asia Breast Cancer Collaborative Group Meeting in 2010 & Guangzhou International Breast Cancer Symposium.